Copertina

Does caring for patients with advanced non-small cell lung cancer affect health-related quality of life of caregivers? A multicenter, cross-sectional study

Abstract Purpose Patients with advanced non-small cell lung cancer (NSCLC) mostly receive essential routine care and support from informal caregivers, who usually experience poorer health-related quality of life (HRQoL). The study aimed to evaluate the HRQoL and its predictors among informal caregiv...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Yi Yang (Autore), Liu Liu (Autore), Jia Chen (Autore), Yuying Gan (Autore), Chunxia Su (Autore), Haibo Zhang (Autore), Enwu Long (Autore), Fei Yan (Autore), Yingyao Chen (Autore)
Natura:	Libro
Pubblicazione:	BMC, 2024-01-01T00:00:00Z.
Soggetti:	article
Accesso online:	Connect to this object online.
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Measuring direct non-medical burden among patients with advanced non-small cell lung cancer in China: is there a difference in health status?
di: Yu Xia, et al.
Pubblicazione: (2023)

A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment
di: Fei Liu, et al.
Pubblicazione: (2021)

Pulmonary adverse events associated with hypertension in non-small cell lung cancer patients receiving PD-1/PD-L1 inhibitors
di: Jianing Chen, et al.
Pubblicazione: (2022)

Comparative efficacy of six programmed cell death Protein-1 inhibitors as first-line treatment for advanced non-small cell lung cancer: a multicenter retrospective cohort study
di: Siyuan Chen, et al.
Pubblicazione: (2024)

Adrenalectomy does not improve survival rates of patients with solitary adrenal metastasis from non-small cell lung cancer
di: Huang S, et al.
Pubblicazione: (2017)

Spatial omics accelerate the study of cancer‐associated fibroblasts in non‐small lung cancer
di: Haozhen Liu, et al.
Pubblicazione: (2024)

Maintenance Chemotherapy With Chinese Herb Medicine Formulas vs. With Placebo in Patients With Advanced Non-small Cell Lung Cancer After First-Line Chemotherapy: A Multicenter, Randomized, Double-Blind Trial
di: Qin Wang, et al.
Pubblicazione: (2018)

Does High Caregiver Stress Predict Nursing Home Entry?
di: Brenda C. Spillman, et al.
Pubblicazione: (2009)

Castasterone, a Plant Steroid Hormone, Affects Human Small-Cell Lung Cancer Cells and Reverses Multi-Drug Resistance
di: David Sadava, et al.
Pubblicazione: (2023)

Clinical significance and biological function of interferon regulatory factor 1 in non-small cell lung cancer
di: Jialin Su, et al.
Pubblicazione: (2024)

Efficacy and safety of Shengjiang Xiexin decoction on irinotecan-induced diarrhea in small cell lung cancer patients: a multicenter, randomized, double-blind, placebo-controlled trial
di: Chao Deng, et al.
Pubblicazione: (2024)

Asymptomatic Congenital Lung Malformations: Timing of Resection Does Not Affect Adverse Surgical Outcomes
di: Vincent Duron, et al.
Pubblicazione: (2020)

Toripalimab plus chemotherapy vs. chemotherapy in patients with advanced non-small-cell lung cancer: A cost-effectiveness analysis
di: Gengwei Huo, et al.
Pubblicazione: (2023)

Rifampicin does not significantly affect the expression of Small heterodimer partner (SHP) in primary human hepatocytes
di: Petr ePavek, et al.
Pubblicazione: (2012)

Does Pre-Service Teacher Preparation Affect Students' Academic Performance? Evidence from China
di: Xinqiao Liu, et al.
Pubblicazione: (2023)

Cost-Effectiveness of Tislelizumab Versus Docetaxel for Previously Treated Advanced Non-Small-Cell Lung Cancer in China
di: Jinhong Gong, et al.
Pubblicazione: (2022)

Predictive value of intra‐tumoural TCRβ rearrangements in precisely selecting adjuvant therapy for EGFR‐mutant non‐small‐cell lung cancer
di: Cunte Chen #, et al.
Pubblicazione: (2022)

Economic Evaluation of First-Line Camrelizumab for Advanced Non-small-cell Lung Cancer in China
di: Guiyuan Xiang, et al.
Pubblicazione: (2021)

Metformin Synergistically Enhanced the Antitumor Activity of Celecoxib in Human Non-Small Cell Lung Cancer Cells
di: Nini Cao, et al.
Pubblicazione: (2020)

Immunotherapy for a POLE Mutation Advanced Non-Small-Cell Lung Cancer Patient
di: Yang Fu, et al.
Pubblicazione: (2022)

Durvalumab-Induced Demyelinating Lesions in a Patient With Extensive-Stage Small-Cell Lung Cancer: A Case Report
di: Wenhui Liu, et al.
Pubblicazione: (2022)

Genetic Association of Drug Response to Erlotinib in Chinese Advanced Non-small Cell Lung Cancer Patients
di: Cong Wang, et al.
Pubblicazione: (2018)

Recent progress of small-molecule of RET inhibitors against Non-small cell lung cancer
di: Jiayi Shen, et al.
Pubblicazione: (2024)

Caregiver Burden of Advance Lung Cancer Patient: a concept analysis
di: Dimas Ria Angga Pribadi, et al.
Pubblicazione: (2022)

Comprehensive analysis of prognostic value and immune infiltration of kindlin family members in non-small cell lung cancer
di: Xiaoshan Su, et al.
Pubblicazione: (2021)

Factors affecting the catch-up growth of preterm infants after discharge in China: a multicenter study based on the health belief model
di: Xiaomei Liu, et al.
Pubblicazione: (2019)

Does Being A Cancer Patient or Family Caregiver of A Cancer Patient Affect Stem Cell Donation Awareness?
di: Gulcan Bagcivan, et al.
Pubblicazione: (2020)

Antagonistic effect of andrographolide on cigarette smoke-induced lung injury in mice
di: Jia-li LIU, et al.
Pubblicazione: (2022)

Stereotactic Body Radiotherapy and Conventional Radiotherapy Induce Cytoskeleton Extension and Enlargement of Cell Morphology in Non-Small Cell Lung Cancer
di: Xiao Wang, et al.
Pubblicazione: (2021)

Assessment of Health-Related Quality of Life Using EuroQoL-5 Dimension in Populations With Prediabetes, Diabetes, and Normal Glycemic Levels in Southwest China
di: Enwu Long, et al.
Pubblicazione: (2021)

miR-26 Induces Apoptosis and Inhibits Autophagy in Non-small Cell Lung Cancer Cells by Suppressing TGF-β1-JNK Signaling Pathway
di: Yi He, et al.
Pubblicazione: (2019)

The cost-effectiveness of cemiplimab plus chemotherapy as the first-line treatment for advanced non-small cell lung cancer
di: Tingting Lu, et al.
Pubblicazione: (2023)

The coexpression of multi-immune inhibitory receptors on T lymphocytes in primary non-small-cell lung cancer
di: Guo WJ, et al.
Pubblicazione: (2017)

Genomic features of Chinese small cell lung cancer
di: Jun Liu, et al.
Pubblicazione: (2022)

Specific TCR profiles predict clinical outcome of adjuvant EGFR-TKIs for resected EGFR-mutant non-small cell lung cancer
di: Si-Yang Maggie Liu, et al.
Pubblicazione: (2023)

Mechanisms of Sepsis-Induced Acute Lung Injury and Advancements of Natural Small Molecules in Its Treatment
di: Yaxi Xu, et al.
Pubblicazione: (2024)

Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp2
di: Shi-Bing Zhang, et al.
Pubblicazione: (2022)

Proteomic analysis reveals the molecular mechanism of Astragaloside in the treatment of non-small cell lung cancer by inducing apoptosis
di: Jiaqi Liu, et al.
Pubblicazione: (2023)

Effect of Osimertinib in Combination With Chemotherapy and Bevacizumab for Untreated Epidermal Growth Factor Receptor-Mutated Advanced Non-Small-Cell Lung Cancer: Case Report
di: Haifeng Qin, et al.
Pubblicazione: (2021)

Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients
di: Peng Cao, et al.
Pubblicazione: (2022)